Olverembatinib (HQP1351), used in combination with low-intensity chemotherapy, has shown encouraging therapeutic potential — along with a favorable safety profile…
Articles by Michela Luciano, PhD
Komzifti (ziftomenib), a once-daily oral therapy approved for certain people with acute myeloid leukemia (AML), is now included in the…
Women prescribed antipsychotics that raise the levels of prolactin, a hormone that stimulates milk production and regulates reproductive hormones,…
A new blood test capable of detecting multiple cancers at earlier, more treatable stages is now available in the U.S.
Linvoseltamab, now branded as Lynozyfic, has received accelerated approval from the U.S. Food and Drug Administration (FDA) for treating adults…
The first patient has been dosed in a Phase 1 clinical trial evaluating the safety and early efficacy of STX-0712…
A new approach in immunotherapy that can safely boost the body’s immune response has shown promise in hard-to-treat tumors like…
CAN-2409 (aglatimagene besadenovec), Candel Therapeutics‘ investigational immunotherapy, was safe and demonstrated potential survival benefits in patients with high-grade…